| Term 
 | Definition 
 
        | adrenoylitc agent alpha antagonist-alpha1 selective, reversible
 
 -used for hypertension
 -used for BPH
 -used for Raynaud's disease
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | adrenoylitc agent alpha antagonist-alpha1 selective, reversible
 
 -used for hypertension
 -used for BPH
 -used for Raynaud's disease
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | adrenoylitc agent alpha antagonist-alpha1 selective, reversible
 
 -used for hypertension
 -used for BPH
 -used for Raynaud's disease
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | adrenoylitc agent alpha antagonist-alpha1 selective, reversible
 
 -NOT used for hypertension
 -used for BPH; predominant drug for BPH because the predominat alpha1 receptor subtype in prostate is alpha1A receptor and this drug has greatest affinity for it
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | adrenoylitc agent alpha antagonist-alpha1 selective, reversible
 
 -NOT used for hypertension
 -used for BPH
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | adrenoylitc agent alpha antagonist-alpha1 selective, reversible
 
 -NOT used for hypertension
 -used for BPH
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | adrenoylitc agent alpha antagonist-non-selective, reversible
 
 -used for pheochromocytoma
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | adrenoylitc agent alpha antagonist- non-selective, irreversible
 
 -used for pheochromocytoma
 |  | 
        |  | 
        
        | Term 
 
        | what's the MOA for the alpha antagonists? |  | Definition 
 
        | block the alpha receptor and prevent the binding of NE or EPI |  | 
        |  | 
        
        | Term 
 
        | describe how alpha blockers used in pheochromocytoma |  | Definition 
 
        | tumor of the adrenal medulla that secretes large amounts of EPI (mostly) and NE, which causes an elevation in BP -blocking alpha1 receptors on vascular smooth m. blocks the ability of Epi and NE to bind to that receptor, thereby cuasing vasodilation and decreasing PVR and a decrease in BP
 |  | 
        |  | 
        
        | Term 
 
        | what's the problem with BPH? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | How are alpha1 antagonists useeful for BPH? |  | Definition 
 
        | blocking alpha1 reeptors relaxes smooth muscle in base of bladder and the prostate 
 END RESULT: improved urine flow
 |  | 
        |  | 
        
        | Term 
 
        | what's the predominate receptor subtype in the prostate? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Which receptor subtype does tamsulosin have the greatest affinity for? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What's the advantage of using tamsulosin for the treatment of BPH? |  | Definition 
 
        | less hypotension (don't get as much vasodilation as with prazosin) |  | 
        |  | 
        
        | Term 
 
        | What's happens in Raynaud's disease? |  | Definition 
 
        | cold --> vasospasm in finger sand toes (painful) 
 --if you block alpha1 receptors then BV dilate and get rid of vasospasm
 |  | 
        |  | 
        
        | Term 
 
        | what are adverse effects of alpha antagonists? |  | Definition 
 
        | -orthostatic hypotension -->1st dose effect: profound orthostatic hypotension with syncope (-> why should take at bedtime 1st time take it)
 
 -reflex tachycardia (prazosin blocks alpha1 and BP decreases-->baroreceptor-->reflex tachycardia)
 
 -nasal congestion (block alpha1 receptors in nasal mucosa)
 -salt and water retention (drop in BP decreases kidney perfusion)
 -inhibition of ejaculation (block alpha1 on smooth m. prostate, seminal vesicles, and vas deferens)
 
 -headache (VS contributes to headache), weakness, dizziness
 |  | 
        |  | 
        
        | Term 
 
        | Baroreceptor reflex effect on heart and BV? |  | Definition 
 
        | stand up-->decrease BP--> baroreceptor acts on CNS which effects: 
 heart: PS acts M receptors and is -; sym act on B1 and get increase HR and force of contraction
 
 BV: sympathetics acts on alpha1 receptors and get vasoconstriction (especially veins) and icnrease BP
 |  | 
        |  | 
        
        | Term 
 
        | why is constriction of veins so important? |  | Definition 
 
        | if no vasoconstriction then blood pools in veins and blood isn't sent back to the heart |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta receptor antagonist non-selective, competitive, reversible
 
 therapeutic uses:
 -CV diseases (hypertension, ischemia, arrhythmias, MI, heart failure)
 -in conjunction with non-selective alpha blocker (i.e. phentolamine or phenoxybenzamine) for pheochromocytoma
 -migraine
 -essential tremor
 -prophylaxis for esophaageal varice bleeding
 
 -adverse effects:
 -CNS (nightmares, lassitude, mental depression)
 -bronchospasm
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta receptor antagonist non-selective, competitive, reversible
 
 therapeutic uses:
 -CV diseases (hypertension, ischemia, arrhythmias, MI, heart failure)
 -in conjunction with non-selective alpha blocker (i.e. phentolamine or phenoxybenzamine) for pheochromocytoma
 -migraine
 -essential tremor
 -prophylaxis for esophaageal varice bleeding
 -bronchospasm
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta receptor antagonist non-selective, competitive, reversible
 
 therapeutic uses:
 -CV diseases (hypertension, ischemia, arrhythmias, MI, heart failure)
 -in conjunction with non-selective alpha blocker (i.e. phentolamine or phenoxybenzamine) for pheochromocytoma
 -migraine
 -essential tremor
 --prophylaxis for esophaageal varice bleeding
 -bronchospasm
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta receptor antagonist non-selective, competitive, reversible
 
 therapeutic uses:
 -CV diseases (hypertension, ischemia, arrhythmias, MI, heart failure)
 -in conjunction with non-selective alpha blocker (i.e. phentolamine or phenoxybenzamine) for pheochromocytoma
 -essential tremor
 -prophylaxis for esophaageal varice bleeding
 -bronchospasm
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta receptor antagonist non-selective, competitive, reversible
 
 therapeutic uses:
 -CV diseases (hypertension, ischemia, arrhythmias, MI, heart failure)
 -in conjunction with non-selective alpha blocker (i.e. phentolamine or phenoxybenzamine) for pheochromocytoma
 -essential tremor
 -prophylaxis for esophaageal varice bleeding
 -bronchospasm
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta receptor antagonist non-selective, competitive, reversible
 
 therapeutic uses:
 -CV diseases (hypertension, ischemia, arrhythmias, MI, heart failure)
 -in conjunction with non-selective alpha blocker (i.e. phentolamine or phenoxybenzamine) for pheochromocytoma
 -essential tremor
 -prophylaxis for esophaageal varice bleeding
 -bronchospasm
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta receptor antagonist Beta1-selective, competitive, reversible
 
 therapeutic uses:
 -CV diseases (hypertension, ischemia, arrhythmias, MI, heart failure)
 -in conjunction with non-selective alpha blocker (i.e. phentolamine or phenoxybenzamine) for pheochromocytoma
 -migraine
 
 -adverse effects: CNS (nightmares, lassitude, mental depression)
 -bronchospasm
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta receptor antagonist Beta1-selective, competitive, reversible (high enough [] will hit Beta 2)
 
 therapeutic uses:
 -CV diseases (hypertension, ischemia, arrhythmias, MI, heart failure)
 -in conjunction with non-selective alpha blocker (i.e. phentolamine or phenoxybenzamine) for pheochromocytoma
 -migraine
 -bronchospasm
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta receptor antagonist Beta1-selective, competitive, reversible
 
 therapeutic uses:
 -CV diseases (hypertension, ischemia, arrhythmias, MI, heart failure)
 -in conjunction with non-selective alpha blocker (i.e. phentolamine or phenoxybenzamine) for pheochromocytoma
 -adverse effect
 bronchospasm
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta receptor antagonist Beta1-selective, competitive, reversible(high enough [] will hit Beta 2)
 
 therapeutic uses:
 -CV diseases (hypertension, ischemia, arrhythmias, MI, heart failure)
 -in conjunction with non-selective alpha blocker (i.e. phentolamine or phenoxybenzamine) for pheochromocytoma
 
 adverse effect:
 -bronchospasm
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta receptor antagonist Beta1-selective, competitive, reversible(high enough [] will hit Beta 2)
 
 therapeutic uses:
 -CV diseases (hypertension, ischemia, arrhythmias, MI, heart failure)
 -in conjunction with non-selective alpha blocker (i.e. phentolamine or phenoxybenzamine) for pheochromocytoma
 
 adverse effect:
 -bronchospasm
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta receptor antagonist Beta1-selective, competitive, reversible(high enough [] will hit Beta 2)
 
 therapeutic uses:
 -CV diseases (hypertension, ischemia, arrhythmias, MI, heart failure)
 -in conjunction with non-selective alpha blocker (i.e. phentolamine or phenoxybenzamine) for pheochromocytoma
 
 adverse effect:
 -bronchospasm
 |  | 
        |  | 
        
        | Term 
 
        | What class of drugs can "BEAM" be used for? |  | Definition 
 
        | beta1 selective, competitive, reversible beta receptor antagonists 
 --all star with the letters B, E, A, or M
 |  | 
        |  | 
        
        | Term 
 
        | What's the MOA for Beta receptor antagonists? |  | Definition 
 
        | bind to, but don't activate beta adrenergic receptors |  | 
        |  | 
        
        | Term 
 
        | what may happen if you administer propranolol (non-selective beta antagonist)without an alpha blocker when treating a pheochromocytoma? |  | Definition 
 
        | there will be more activation of the alpha1 receptor, BP will increase, and you'll have unopposed VC b/c have gotten rid of the Beta2 effect; get dramatic increase BP |  | 
        |  | 
        
        | Term 
 
        | What are beta receptor antagonists' effect on migraines? |  | Definition 
 
        | prophylactic treatment; reduce frequency, severity, and duration of migraine attacks; precise MOA unknown |  | 
        |  | 
        
        | Term 
 
        | what's a theory how blocking beta receptors can be helpful for migraines? |  | Definition 
 
        | prevent arterial dilation; inhibit renin secretion; decrease AA synthesis and prostaglandin production; may affect serotonin levels |  | 
        |  | 
        
        | Term 
 
        | What kind of drug do you use to treat essential tremors? why? |  | Definition 
 
        | non-selective beta blocker (i.e. propranolol) because B2 receptors on red, slow contrating skeletal m. cause tremor |  | 
        |  | 
        
        | Term 
 
        | What's the main cause of esophageal varices? |  | Definition 
 
        | cirrhosis of the liver and portal hypertension |  | 
        |  | 
        
        | Term 
 
        | what are adverse effects with beta receptor antagonists? |  | Definition 
 
        | cardiac: bradycardia, AV block, decrease contractile force --> heart failure; hypotension 
 CNS: nigtmares, lassitude/fatigue, mental depression, insomnia
 --->w/lipid-soluble agents (propranolol, metoprolol)
 -NVD?
 -sexual dysfunction
 -increase TAG and decrease HDL-C (not a reason to not use these drugs)
 -Bronchospasm
 -unopposed VC in patients with peripheral vascular disease b/c no B2 activity
 -chronic therapy upregulates beta receptors so if have abrupt withdrawal get rebound hypertension, nervousness, tachycardia, angina
 |  | 
        |  | 
        
        | Term 
 
        | what are some precautions with beta receptor antagonists? |  | Definition 
 
        | Diabetics --> hypoglycemia-->activate sympathetic NS; release EPI; EPI/NE act on B2 in the liver-->glycogenolysis and gluconeogenesis-->increase blood glucose and they act on B1 in the heart-->increase HR--> warning sign to eat
 |  | 
        |  | 
        
        | Term 
 
        | Both non-selective and B1 selective blockers are contraindicated in asthma. Why? |  | Definition 
 
        | the selectivity of Beta1 blockers may be lost at higher doses 
 -blocking Beta2 receptors causes bronchoconstriction and thus bronchospasm
 |  | 
        |  |